newsfilter
← Latest News
GlobeNewswire·

Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections

NEWTOWN, Pa., May 08, 2026 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (NASDAQ:TRAW) ("Traws Pharma", "Traws" or "the Company"), a clinical-stage biopharmaceutical company developing novel therapies to target critical